European Pregnancy and Paediatric HIV Cohort Collaboration
EPPICC is a multi-country cohort collaboration conducting epidemiological research on pregnant women and children living with HIV, and children exposed to HIV in utero.
What is this study about?
EPPICC’s programme of work encompasses individual patient data meta-analyses, pharmacovigilance projects and other observational studies. This programme focuses on scientific questions requiring a large sample size of patients, which the contributing cohorts cannot answer individually and/or which do not overlap with existing projects or collaborations between participating cohorts.
EPPICC is part of the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration which brings together the largest collaboration of paediatric and adolescent HIV observational cohort networks to date.
EPPICC forms part of the PENTA network. It is coordinated at University College London (UCL), jointly by the MRC Clinical Trials Unit and the UCL Great Ormond Street Institute of Child Health.
Type of study
Who is funding the study?
EPPICC is primarily funded by pharmaceutical companies through its pharmacovigilance programme of work. It has also received funding from the IAS Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) initiative, and was part of the European Union’s Seventh Framework Programme for research, technological development and demonstration under EuroCoord grant agreement number 260694.
When is it taking place?
EPPICC is an ongoing cohort collaboration which started in 2011.
Where is it taking place?
EPPICC includes cohorts from 18 countries across Eastern and Western Europe and also Thailand.
Who is included?
Our studies focus on pregnant women and children living with HIV, and children exposed to HIV in utero, who are followed in our collaborating observational cohorts.